Pulmonx reported a 17% increase in revenue compared to the same quarter last year, with a relatively flat gross margin. The company completed an initial public offering, raising approximately $201.4 million. They also secured a positive coverage decision for Zephyr Valve from Health Care Service Corporation, adding 16 million additional lives under coverage.
Reported revenue of $10.6 million, a 17% increase over the same period last year.
Achieved gross margin of 70.3%, relatively flat compared to the third quarter of 2019.
Completed an initial public offering of 11.5 million shares, raising approximately $201.4 million in net proceeds.
Secured a positive coverage decision for Zephyr Valve from Health Care Service Corporation, adding 16 million additional lives under coverage
Pulmonx expects full year 2020 revenue to be in the range of $31.5-$32.0 million, while acknowledging the continued risk of uncertainty due to the COVID-19 pandemic.
Analyze how earnings announcements historically affect stock price performance